Hawk Ridge Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Hawk Ridge Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,900	Closed	-$1.28M	–	48
2023 Q1	$1.28M	Buy	+35,900	New	+$1.3M	0.07%	38
2020 Q1	–	Sell	-502,362	Closed	-$29.9M	–	56
2019 Q4	$29.9M	Buy	502,362 +121,171	+32%	+$6.51M	4.86%	7
2019 Q3	$20.3M	Hold	381,191	–	–	4.07%	10
2019 Q2	$19.5M	Hold	381,191	–	–	3.61%	8
2019 Q1	$19.7M	Buy	+381,191	New	+$18.5M	4.16%	7
2018 Q4	–	Sell	-477,300	Closed	-$24.6M	–	50
2018 Q3	$24.6M	Buy	477,300 +195,500	+69%	+$9.57M	5.41%	2
2018 Q2	$13.2M	Hold	281,800	–	–	3.06%	9
2018 Q1	$10M	Buy	281,800 +160,800	+133%	+$6.3M	2.92%	16
2017 Q4	$5.28M	Buy	+121,000	New	+$5.65M	1.75%	21

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Hawk Ridge Capital Management's SYNH Position: Q2 2023 in Review

Hawk Ridge Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 35,900 shares — an estimated $1.28M sold.

Hawk Ridge Capital Management first reported a position in SYNH in Q4 2017 and held it in 9 quarters. The position peaked at $29.9M in Q4 2019. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Hawk Ridge Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Hawk Ridge Capital Management sold 35,900 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.28M.
Hawk Ridge Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 9 quarters.
Hawk Ridge Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $29.9M in Q4 2019.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Hawk Ridge Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.